Organism 63669 - Rhodiola sacra (CRASSULACEAE)

Organisms in NAP refer to specimens, they are not "taxonomical" organisms and they can in some cases even be mixtures of organisms. Empty organisms are used as placeholders as the original dataset entry system used organism as the central part.
Search for all experiments on this taxon

Organism Details

PropertyValue
Taxon46766
FamilyCRASSULACEAE
GenusRHODIOLA
SpeciesSACRA
Species authority(PRAIN EX HAMET) S.H.FU
Subspecies
Subspecies authority
Comment
CitationYOSHIKAWA,M: SHIMADA,H: HORIKAWA,S: MURAKAMI,T: SHIMODA,H: YAMAHARA,J: MATSUDA,H:. (1997). BIOACTIVE CONSTITUENTS OF CHINESE NATURAL MEDICINES. IV. RHODIOLAE RADIX. (2).: ON THE HISTAMINE RELEASE INHIBITORS FROM THE UNDERGROUND PART OF RHODIOLA SACRA (PRAIN EX HAMET) S.H. FU (CRASSULACEAE): CHEMICAL STRUCTURES OF RHODIOCYANOSIDE D AND. 45(9)
Geographical areaEASTERN ASIA
CountryCHINA

Experiments

Filters
Worktypes (10)
11
8
8
3
3
3
3
3
1
1
No match
Pharmacology (2)
9
11
No match
Compounds (12)
2
2
2
2
2
2
2
2
1
1
1
1
No match
20 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
210714
PHARMACOLOGY OF EXTRACT - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
210715
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Rhodiola sacra (CRASSULACEAE)
RHODIOCYANOSIDE D
210716
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
RHODIOCYANOSIDE D
210717
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Rhodiola sacra (CRASSULACEAE)
SACRANOSIDE A
210718
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
SACRANOSIDE A
210719
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Rhodiola sacra (CRASSULACEAE)
SACRANOSIDE B
210720
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
SACRANOSIDE B
210721
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
RHODIOCYANOSIDE A
210722
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
HETERODENDRIN
210723
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
HETERODENDRIN
210724
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
LOTAUSTRALIN
210725
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
LOTAUSTRALIN
210726
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
RHODIOLOSIDE
210727
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
PHENYLETHANOL,2: ALPHA-L-ARABINOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE
210728
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
PHENYLETHANOL,2: ALPHA-L-ARABINOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSIDE
210729
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
BUT-3-EN-2-OL,2-METHYL: BETA-D-GLUCOPYRANOSIDE
210730
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
KENPOSIDE A
210731
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
KENPOSIDE A
210732
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Rhodiola sacra (CRASSULACEAE)
RHODIOOCTANOSIDE
210733
PHARMACOLOGY OF COMPOUND - IN VITRO
HISTAMINE RELEASE INHIBITION
Rhodiola sacra (CRASSULACEAE)
RHODIOOCTANOSIDE
Show SPARQL Queries (1)